Affiliation:
1. Vacord-Bioengineering Research Company Ltd., Brno - Czechoslovakia
2. HP Medica, Augsburg - Germany
3. Institute of Pathophysiology, Masaryk University, Brno
4. Medica Co. Ltd. Brno - Czechoslovakia
Abstract
Long-term experiments with the total artificial heart (TAH) are a source of valuable knowledge for later clinical application. Our observations result from 66 long-term experiments on calves and one goat ranging from 30 to 314 days, which have shown the main possible complications in the early period (one month) and later in the experiment. Problems until the second month of pumping concern the clinical pendant of the TAH as a bridge for transplantation, i.e. surgical problems, blood coagulation disorders, infection etc. Later problems are high venous pressure or arterial hypertension, infection with septic thromboembolization, mineralization of the driving diaphragm, etc., and are more closely comparable to the conditions of permanent clinical use of the TAH. Faultless surgery, device function and the regimen of pumping are essential factors in every long-term experiment, just as in clinical application. Infection is a threat throughout any experiment, as in clinical cases. The TNS-BRNO-VII/clin/80 TAH has been implanted in six patients.
Subject
Biomedical Engineering,Biomaterials,General Medicine,Medicine (miscellaneous),Bioengineering
Reference13 articles.
1. VaskuJ. Artificial heart. Pathophysiology of the total artificial heart and of cardiac assist devices. Brno: University of J Ev Purkyne press 1982; 397.
2. VaskuJ. Brno-Experiments in long term survival with total artificial heart. Brno: University of J Ev. Purkyne press 1984; 622.
3. Evaluation Study of Calves with Total Artificial Heart (TAH) Surviving for 218-293 Days of Pumping
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献